BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Kalaris Therapeutics\, Inc. (KLRS) investor events
X-WR-CALNAME:Kalaris Therapeutics\, Inc. (KLRS) investor events
DESCRIPTION:Earnings calls and investor events for Kalaris Therapeutics\, I
 nc. (KLRS)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Kalaris Therapeutics\, 
 Inc. (KLRS)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:15d2369e-42f2-4604-a813-9c99df07c8c9@equibles.com
DTSTAMP:20260617T191245Z
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:7efb749d-6875-44ae-8e8b-2ba485568ff8@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251114
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Conference: Stifel 2025 Annual H
 ealthcare Conference
DESCRIPTION:Stifel 2025 Annual Healthcare Conference\nThe start time has no
 t been announced.\nWebcast: https://investors.kalaristx.com/events/event-d
 etails/stifel-2025-annual-healthcare-conference
END:VEVENT
BEGIN:VEVENT
UID:e391a555-4653-4c3a-90fe-82c3407086c8@equibles.com
DTSTAMP:20260624T233140Z
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Conference: Noble Capital Market
 s 21st Annual Emerging Growth Equity Conference
DESCRIPTION:Noble Capital Markets 21st Annual Emerging Growth Equity Confer
 ence\nThe start time has not been announced.\nWebcast: https://investors.k
 alaristx.com/events/event-details/noble-capital-markets-21st-annual-emergi
 ng-growth-equity-conference
END:VEVENT
BEGIN:VEVENT
UID:f393fbd5-f09d-42a6-a395-5aae0acb77d7@equibles.com
DTSTAMP:20260617T191054Z
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260318
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:124cb22f-2dcc-4ee1-b278-a75b82c084e3@equibles.com
DTSTAMP:20260617T191047Z
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260513
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:2c9c32d0-2bcb-4a41-85f9-5bd669be7dd3@equibles.com
DTSTAMP:20260718T145003Z
DTSTART;VALUE=DATE:20260717
DTEND;VALUE=DATE:20260718
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Annual General Meeting: TH103 Ph
  1a Data Presentation at American Society of Retina Specialists Annual Mee
 ting 2026
DESCRIPTION:TH103 Ph 1a Data Presentation at American Society of Retina Spe
 cialists Annual Meeting 2026\nThe start time has not been announced.\nWebc
 ast: https://investors.kalaristx.com/events/event-details/th103-ph-1a-data
 -presentation-american-society-retina-specialists-annual
END:VEVENT
BEGIN:VEVENT
UID:99dfa02c-ea82-489f-851c-e77032e13f71@equibles.com
DTSTAMP:20260919T183804Z
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260916
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Kalaris Therapeutics\, Inc. (KLRS) Conference: Morgan Stanley 24th 
 Annual Global Healthcare Conference
DESCRIPTION:Morgan Stanley 24th Annual Global Healthcare Conference\nThe st
 art time has not been announced.\nWebcast: https://investors.kalaristx.com
 /events/event-details/morgan-stanley-24th-annual-global-healthcare-confere
 nce
END:VEVENT
END:VCALENDAR
